In the BioHarmony Drug Report Database

"Preview" Icon

Plicamycin

Mithracin (plicamycin) is a small molecule pharmaceutical. Plicamycin was first approved as Mithracin on 1982-01-01. It is used to treat bcr-abl positive chronic myelogenous leukemia, extramammary paget disease, hypercalcemia, and testicular neoplasms in the USA.

 

Trade Name

 

Mithracin
 

Common Name

 

plicamycin
 

ChEMBL ID

 

CHEMBL1237054
 

Indication

 

bcr-abl positive chronic myelogenous leukemia, extramammary paget disease, hypercalcemia, testicular neoplasms
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Plicamycin structure rendering